Literature DB >> 33502319

Efficacy of Mepolizumab Extended Interval Dosing for 2 Asthmatic Patients With Chronic Eosinophilic Pneumonia.

H Sato1, Y Miyata1, H Inoue1, A Tanaka1, H Sagara1.   

Abstract

Entities:  

Keywords:  Anti-IL-5 monoclonal antibody; Asthma; Chronic eosinophilic pneumonia; Extended interval dosing; Mepolizumab

Mesh:

Substances:

Year:  2021        PMID: 33502319     DOI: 10.18176/jiaci.0671

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  1 in total

1.  Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma.

Authors:  Georg Bölke; Xunliang Tong; Torsten Zuberbier; Jean Bousquet; Karl-Christian Bergmann
Journal:  World Allergy Organ J       Date:  2022-10-01       Impact factor: 5.516

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.